1093.HK

CSPC Pharmaceutical Group Ltd · Healthcare · Drug Manufacturers - General

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$11.33B

PE Ratio

11.07

EV to Ebitda

—

Earnings Yield

9.00%

Revenue (TTM)

$3.35B

Net Income (TTM)

$1.02B

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

3.00%

Profit Margin

15.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$11.33B

Revenue TTM$3.35B

Shares Outstanding11.42B

Float8265820503

Insider Ownership32.00%

Institutional Ownership30.00%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)3.00%

Rev Growth Est 1Y Forward0.06

EPS Growth (Quarterly YoY)30.00%

EPS Growth Est Quarterly0.13

LT EPS Growth Estimates10.00%

Operations18 fields›

Revenue TTM$3.35B

Gross Margin TTM66.00%

Gross Margin (Quarterly)66.00%

Operating Margin TTM13.00%

Operating Margin (Quarterly)18.00%

Operating Expenses TTM$5.7M

Profit Margin TTM15.00%

Profit Margin (Quarterly)42.00%

Net Income TTM$1.02B

EPS TTM0.38

EPS (Quarterly)0.24

EBIT Margin TTM24.60%

EBITDA Margin TTM21.00%

EBITDA TTM$692.4M

CFO % of Revenue (Quarterly)54.00%

Capex % of Revenue TTM10.00%

Capital Expenditures$330.7M

FCF % of Revenue (Quarterly)7.00%

Efficiency1 fields›

ROA6.00%

Valuation8 fields›

P/E (TTM)11.07

P/E Forward17.04

PEG2.7

EV/Revenues (TTM)3.14

Price To Book2.67

Price to Tangible Book2.92

Earnings Yield9.00%

Payout Ratio63.00%

Liquidity8 fields›

Cash Per Share0.7

Current Ratio2.27

Goodwill & Intangibles$2890.26T

Total Assets$5.87B

Total Liabilities$5.62B

Shareholders Equity$4.25B

Interest Expense$5.7M

Goodwill % of Assets6282844.00%

Yields3 fields›

Payout Ratio63.00%

Earnings Yield9.00%

Buyback Yield-4.00%